Business Daily Media

Men's Weekly

.

Immuno Cure BioTech acquires Shanghai Teresa Healthcare

Integrating Electroporation Technology & DNA Vaccine Platforms

HONG KONG SAR - Media OutReach - 20 September 2022 - Immuno Cure BioTech, a clinical stage biotechnology group based in the Hong Kong Science Park specialising in DNA vaccines and immunotherapies, announced today the acquisition of 92.6% of Shanghai Teresa Healthcare, the pioneer of electroporation technology and device in China.

The transaction will be settled in cash and shares. Teresa's shareholders will swap for about 1.5% equity in Immuno Cure while the inventor of Teresa's EP technology, Professor XU Yuhong (徐宇虹), maintains her 7.4% direct equity in Teresa.

Teresa EP device delivers brief electrical pulses to promote efficient penetration of DNA vaccine through cell membrane for the enhancement of gene expression and ultimate immune responses. It is the only such device approved by National Medical Products Administration for the administration of DNA vaccine in China. Such EP technology has been an integral part of Immuno Cure's DNA vaccine delivery strategy from research to clinical stage.

Founded in 2004, Shanghai Teresa is an innovative medical device group focusing in electro immunotherapies and rehabilitation therapies. In 2005, Teresa's electroporation technology was developed to enhance the delivery of DNA medicine, based on the intellectual property generated by Shanghai Jiao Tong University under the National 863 Project. Such EP technology has been proven safe and efficacious after deployment of over 10,000 times in collaboration with more than thirty hospitals for the administration of DNA medicine in numerous human trial subjects.

Immuno Cure has two PD-1-Enhanced DNA vaccines currently in phase 1 clinical trial for prevention of COVID-19 and therapeutic cure of HIV/AIDS.

Dr JIN Xia, CEO of Immuno Cure said, "Immuno Cure has partnered with Teresa over the years in developing customised EP delivery strategy for our PD-1-Enhanced DNA vaccines, which has brought about encouraging results in clinical setting recently. I am pleased with this convergence with Teresa, which will no doubt bring our teams even closer together. Teresa will continue to operate independently while leveraging on Immuno Cure's R&D platform for the development of their next generation non-invasive EP technology for intradermal delivery strategy. Immuno Cure is committed to support the continual growth and success of Teresa."

Ms. CHEN Liye, CEO of Teresa said, "Founded on our long term collaboration, Teresa is excited to become a member of Immuno Cure Group. This move will not only provide us with a much closer R&D relationship, which is essential for our technology advancement but also offer us the financial capability to meet future needs. Teresa treasures our collaborations with other players in the field and look forward to continuing our collaborations with new and sustainable EP technology."

Professor CHEN Zhiwei, Director of AIDS Institute at the University of Hong Kong and the Principal Scientific Advisor of Immuno Cure said, "Our research and development work at the AIDS Institute and Immuno Cure has benefitted from Teresa's EP technology and their diligent collaborative effort over the past 12 years. I am pleased to see their relationship developing into an even closer tie. Look forward to the development of the next generation of EP technology for further optimisation of delivery strategy and patient experience."

Dr Percy CHENG, Chairman of Immuno Cure concludes, "This transaction offers Immuno Cure the opportunity to secure Teresa's EP technology for support of not only R&D but also the clinical administration of our PD-1-Enhanced DNA vaccines. We are pleased with Professor XU's decision to remain as our co-investor in Teresa and are optimistic in the future of EP technology in our DNA vaccine development."Hashtag: #ImmunoCureBiotech

The issuer is solely responsible for the content of this announcement.

Immuno Cure BioTech

Immuno Cure BioTech is a clinical stage biotechnology group based in the Hong Kong Science Park, focusing on research and development of vaccines and immunotherapies for cancers, inflammatory and infectious diseases based on its patented PD-1-Enhanced DNA vaccine and Anti-Δ42PD1 Blocking Antibody technology platforms.

To learn more about Immuno Cure BioTech, please visit

Shanghai Teresa Healthcare

Founded in 2004, Shanghai Teresa is an innovative medical device group based in Shanghai Zhangjiang Hi-Tech Park, focusing in electro immunotherapies and rehabilitation therapies.

To learn more about Shanghai Teresa Healthcare, please visit




News from Asia

Trusted by Millions: FBS Wins Best Islamic Forex Broker Asia 2025

SINGAPORE - Media OutReach Newswire - 3 September 2025 - FBS, a leading global broker, announces its latest recognition as the Best Islamic Forex Broker Asia 2025. The BRM awards highlight FBS’s...

Malaysia’s ASEAN Chairmanship Supercharges NSS in Global Chip Race

KUALA LUMPUR, MALAYSIA - Media OutReach Newswire - 3 September 2025 - Malaysia's semiconductor ambitions are moving in step with its role as ASEAN chair, with investment momentum signalling a larg...

Aon Study Highlights Strategic Wellbeing Imperatives for Chinese Insurers to Build Capability and Address Medical Inflation Costs

Only one-third of insurers in China provide mental health services, despite rising demand Fifty percent of insurers see personalisation as key to the success of health and wellbei...

MyRepublic Launches AI Automation Box, An Industry-First Plug-and-Play AI Server That Lets SMEs Automate Their Business

SINGAPORE - Media OutReach Newswire - 3 September 2025 - MyRepublic today announced the launch of the AI Automation Box, a plug-and-play AI automation server designed for small and medium-sized en...

McLaren Racing Announces Trend Micro as an Official Partner of the McLaren Formula 1 Team

High-performance alliance built to stay ahead, on track and in cybersecurityHONG KONG SAR - Media OutReach Newswire - 3 September 2025 - Trend Micro Incorporated (TYO: 4704; TSE: 4704), a global ...

Luxshare Precision Announces 2025 Interim Results, IPO in Hong Kong Further Expands Global Competitiveness

HONG KONG SAR - Media OutReach Newswire - 3 September 2025 - Luxshare Precision (002475.SZ) released its 2025 Interim Report at the end of last month. Under the complex and ever-changing global ec...

Hong Kong Disneyland Resort Celebrates Earth Month by Transforming Main Street Taxi

Resort gives vintage amusement ride a magic touch, converting to electric powerHONG KONG SAR - Media OutReach Newswire – 11 April 2025 - In celebration of Earth Month this April, Hong Kong Disneyl...

Berlin Women’s Choir Performs in Yanguan, Fostering Cultural Exchange with Pure Female Voices

JIAXING, CHINA - Media OutReach Newswire - 2 September 2025 - On the evening of August 28, 2025, the Berlin Women's Choir from Germany gave a concert at the Yanguan Theatre, conducted by renowned ...

Gwofy Launches On-Chain Receivables Verification to Ease Cash-Flow Strains in Cross-Border E-Commerce

HONG KONG SAR - EQS Newswire - 4 September 2025 - Cross-border e-commerce service platform Gwofy has launched a new on-chain receivables verification solution. Through merchant-authorized APIs, t...

Galaxy Macau and UFC® Announce Multi-Event Strategic Partnership Agreement To Bring Three UFC Events to Galaxy Arena

Starting in 2026 with UFC® FIGHT NIGHT MACAU and ROAD TO UFC Season 5 Opening RoundMACAU SAR - Media OutReach Newswire - 4 September 2025 - Galaxy Macau™ Integrated Resort (hereinafter as "Galaxy ...

Changing the World One Bite At a Time: IKU Turns 40

One of Australia’s first plant-based, chef-led eateries and now ready meal provider IKU is celebrating its 40 year anniversary with the business e...

Three generations marking 45 years in hot-air balloons

Australia’s leading hot-air balloon company is celebrating 45 years in the sky and its 700,000th passenger, driven by the passion of father-son du...

Workplace DMs, Reinvented: Deputy Messaging, Purpose-Built For Shift-Based Teams

Deputy, the global people platform for shift-based businesses, has launched Deputy Messaging, a fully integrated, real-time communication tool designe...

Revolutionizing Fulfillment: How Virtual Warehousing is Changing the Game?

The e-commerce landscape is evolving more rapidly than ever, and the way businesses are managing their fulfillment is also revolutionizing. At the...

SME lender Dynamoney welcomes new CEO, Brett Thomas

Strengthens growth ambitions and signals expanded offering Dynamoney, a leading commercial finance provider for Australian SMEs,  has today appoint...

The cost of ignoring AI governance in business

Artificial intelligence (AI) is no longer the promise of a distant future: it's active, embedded, and already shaping decisions across industries. H...

Sell by LayBy